Physician profile
Srikanth A Sundaram
NPI 1780610543
$492,833.30
in general payments reported to CMS, 2019-2025
30 companies · $103K in 2025
The $103K reported for 2025 was more than what 98% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $48K · 2021: $58K · 2022: $43K · 2023: $117K · 2024: $102K · 2025: $103K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $217K · Travel and Lodging: $65K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $216,788.75 |
| Travel and Lodging | $64,631.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,450.00 |
| Food and Beverage | $15,110.41 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,725.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $438,999.95 | 2019-2025 | Ensite, Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled |
| Boston Scientific Corporation | $25,246.24 | 2019-2025 | Farapulse, General - Therapies, Watchman Access System |
| Medtronic Vascular, INC. | $12,267.35 | 2019-2020 | |
| Medtronic, INC. | $10,121.85 | 2021-2025 | Micra, Affera Mapping System, Cobalt Dr Mri Surescan |
| Altathera Pharmaceuticals LLC | $1,997.44 | 2025 | Sotalol Hydrochloride |
| Impulse Dynamics (USA) INC. | $1,099.46 | 2022-2025 | Optimizer, Optimizer |
| Cardiofocus, INC. | $992.61 | 2019 | |
| Omega Medical Imaging, LLC | $419.63 | 2025 | |
| Pfizer INC. | $249.51 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $249.06 | 2019-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $213.79 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Amgen INC. | $203.41 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $196.23 | 2020-2023 | Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $94.38 | 2025 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $69.16 | 2022-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $65.16 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.04 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.23 | 2022 | |
| Sanofi-Aventis U.S. LLC | $41.88 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $35.78 | 2025 | Wainua |
| Janssen Pharmaceuticals, INC | $26.17 | 2019-2021 | |
| Cvrx, INC. | $21.05 | 2025 | Barostim Neo System |
| Gilead Sciences, INC. | $19.71 | 2019 | |
| Scpharmaceuticals INC. | $18.74 | 2025 | |
| Astellas Pharma US INC | $15.95 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $15.34 | 2023 | Inpefa |
| Atricure, INC. | $14.82 | 2024 | |
| Lilly USA, LLC | $14.37 | 2025 | Mounjaro, Zepbound |
| Heartflow, INC. | $13.99 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srikanth Sundaram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.